Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness

The rising incidence and mortality rate associated with the metastatic ability of cutaneous melanoma represent a major public health concern. Cutaneous melanoma is one of the most invasive human cancers, but the molecular mechanisms are poorly understood. Moreover, currently available therapies are...

Full description

Bibliographic Details
Main Authors: Cheila Brito, Duarte C. Barral, Marta Pojo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2020.575223/full
_version_ 1828446217504292864
author Cheila Brito
Duarte C. Barral
Marta Pojo
author_facet Cheila Brito
Duarte C. Barral
Marta Pojo
author_sort Cheila Brito
collection DOAJ
description The rising incidence and mortality rate associated with the metastatic ability of cutaneous melanoma represent a major public health concern. Cutaneous melanoma is one of the most invasive human cancers, but the molecular mechanisms are poorly understood. Moreover, currently available therapies are not efficient in avoiding melanoma lethality. In this context, new biomarkers of prognosis, metastasis, and response to therapy are necessary to better predict the disease outcome. Additionally, the knowledge about the molecular alterations and dysregulated pathways involved in melanoma metastasis may provide new therapeutic targets. Members of the Ras superfamily of small GTPases regulate various essential cellular activities, from signaling to membrane traffic and cytoskeleton dynamics. Therefore, it is not surprising that they are differentially expressed, and their functions subverted in several types of cancer, including melanoma. Indeed, Ras small GTPases were found to regulate melanoma progression and invasion. Hence, a better understanding of the mechanisms regulated by Ras small GTPases that are involved in melanoma tumorigenesis and progression may provide new therapeutic strategies to block these processes. Here, we review the current knowledge on the role of Ras small GTPases in melanoma aggressiveness and the molecular mechanisms involved. Furthermore, we summarize the known involvement of these proteins in melanoma metastasis and how these players influence the response to therapy.
first_indexed 2024-12-10T22:08:46Z
format Article
id doaj.art-7e15614e414846ad9b471ed382752435
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-10T22:08:46Z
publishDate 2020-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-7e15614e414846ad9b471ed3827524352022-12-22T01:31:40ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-09-01810.3389/fcell.2020.575223575223Subversion of Ras Small GTPases in Cutaneous Melanoma AggressivenessCheila Brito0Duarte C. Barral1Marta Pojo2Unidade de Investigação em Patobiologia Molecular (UIPM) do Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Lisbon, PortugalCEDOC, Faculdade de Ciências Médicas, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, PortugalUnidade de Investigação em Patobiologia Molecular (UIPM) do Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Lisbon, PortugalThe rising incidence and mortality rate associated with the metastatic ability of cutaneous melanoma represent a major public health concern. Cutaneous melanoma is one of the most invasive human cancers, but the molecular mechanisms are poorly understood. Moreover, currently available therapies are not efficient in avoiding melanoma lethality. In this context, new biomarkers of prognosis, metastasis, and response to therapy are necessary to better predict the disease outcome. Additionally, the knowledge about the molecular alterations and dysregulated pathways involved in melanoma metastasis may provide new therapeutic targets. Members of the Ras superfamily of small GTPases regulate various essential cellular activities, from signaling to membrane traffic and cytoskeleton dynamics. Therefore, it is not surprising that they are differentially expressed, and their functions subverted in several types of cancer, including melanoma. Indeed, Ras small GTPases were found to regulate melanoma progression and invasion. Hence, a better understanding of the mechanisms regulated by Ras small GTPases that are involved in melanoma tumorigenesis and progression may provide new therapeutic strategies to block these processes. Here, we review the current knowledge on the role of Ras small GTPases in melanoma aggressiveness and the molecular mechanisms involved. Furthermore, we summarize the known involvement of these proteins in melanoma metastasis and how these players influence the response to therapy.https://www.frontiersin.org/article/10.3389/fcell.2020.575223/fullras Small GTPasesbiomarkersmetastasiscancer progressioncancer therapiescutaneous melanoma
spellingShingle Cheila Brito
Duarte C. Barral
Marta Pojo
Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness
Frontiers in Cell and Developmental Biology
ras Small GTPases
biomarkers
metastasis
cancer progression
cancer therapies
cutaneous melanoma
title Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness
title_full Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness
title_fullStr Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness
title_full_unstemmed Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness
title_short Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness
title_sort subversion of ras small gtpases in cutaneous melanoma aggressiveness
topic ras Small GTPases
biomarkers
metastasis
cancer progression
cancer therapies
cutaneous melanoma
url https://www.frontiersin.org/article/10.3389/fcell.2020.575223/full
work_keys_str_mv AT cheilabrito subversionofrassmallgtpasesincutaneousmelanomaaggressiveness
AT duartecbarral subversionofrassmallgtpasesincutaneousmelanomaaggressiveness
AT martapojo subversionofrassmallgtpasesincutaneousmelanomaaggressiveness